Title Salinomycin and dichloroacetate synergistically inhibit Lewis lung carcinoma cell proliferation, tumor growth and metastasis /
Authors Skeberdytė, Aistė ; Sarapinienė, Ieva ; Krasko, Jan Aleksander ; Barakauskienė, Aušrinė ; Žilionytė, Karolina ; Prokarenkaitė, Rimvilė ; Sužiedėlis, Kęstutis ; Bukelskienė, Virginija ; Jarmalaitė, Sonata
DOI 10.1016/j.bbrc.2019.12.107
Full Text Download
Is Part of Biochemical and biophysical research communications.. San Diego : Elsevier. 2020, vol. 523, no. 4, p. 874-879.. ISSN 0006-291X. eISSN 1090-2104
Keywords [eng] Lung neoplasms ; Carcinoma, lewis lung ; Pyrans ; Dichloroacetic acid ; Cell line, tumor ; Drug synergism
Abstract [eng] Drug combination is considered to be the cornerstone of cancer treatment. Simultaneous administration of two or more drugs but at lower doses not only increases cytotoxic effects on tumor cells, but also reduces side effects and possibly overcomes drug resistance. Salinomycin is a well-known cancer stem cell killer, and dichloroacetate is a pyruvate dehydrogenase kinase inhibitor that exclusively targets cells with altered mitochondrial activity, a characteristic being common to most of the cancer cells. In our recent study, we have demonstrated that salinomycin exerted a cytotoxic effect on colorectal carcinoma cells in the 2D and 3D cultures and provided evidence that the mechanism of their synergy was mediated by dichloroacetate-dependent inhibition of the activity of multidrug resistance proteins. In the current work, we confirmed the synergistic cytotoxic properties of salinomycin and dichloroacetate in the 2D and 3D cultures of Lewis lung carcinoma (LLC1) cells. To verify if a synergistic effect of these compounds persisted in vivo, we performed series of experiments using a syngeneic LLC1-C57BL/6 mouse model and demonstrated that combination therapy with salinomycin and DCA increased the survival rate of allografted mice, inhibited metastatic site formation and reduced the populations of cancer stem cells as well as cells that underwent the epithelial-to-mesenchymal transition. Our results demonstrate that a synergistic effect of salinomycin and dichloroacetate exists not only in vitro but also in vivo and suggest their benefits in the treatment of metastatic cancers.
Published San Diego : Elsevier
Type Journal article
Language English
Publication date 2020